The emergence of a combined TP53 mutation and MYCN amplification at relapse proved to be a feature that occurs irrespective of the medulloblastoma subgroup, involves specific combinations of events not observed at diagnosis, and it is associated with rapid progression to death [46]. Here, TP53 is linked to medulloblastoma.